Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III)
Clinical trial NCT04204096 · COMPLETED
Trial details
- NCT number
- NCT04204096
- Sponsor
- International Vaccine Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-04
- Primary completion
- 2020-09-11
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.